E. Tackey

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.

P. Lipsky, G. Illei, T. Fleisher, 2010, Arthritis and rheumatism.

Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability.

P. Lipsky, G. Illei, E. Tackey, 2004, Arthritis and rheumatism.

Rationale for interleukin-6 blockade in systemic lupus erythematosus

P. Lipsky, G. Illei, E. Tackey, 2004, Lupus.

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

P. Lipsky, G. Illei, E. Tackey, 2004, Arthritis and rheumatism.